Brief: Janux Therapeutics Q2 Basic EPS USD -0.35
06/08/2026 21:03
BRIEF-Janux Therapeutics Q2 Basic EPS USD -0.35 Aug 06 (Reuters) - Janux Therapeutics Q2 operating income USD -31.69 million.
- Q2 collaboration revenue USD 10.267 million
- Q2 operating expenses USD 41.957 million
- Q2 net income USD -21.972 million